NCT01430260

Omnaris Versus Levocetirizine Phase 4 Study

A Multi-center, Open, Randomized, Three-arm, Parallel-group, Phase IV Study to Compare the Efficacy of Ciclesonide Nasal Spray and Levocetirizine, Alone and in Combination for the Patient With Allergic Rhinitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 349 (actual)
• Sponsor: Handok Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This i a comparison of the efficacy ciclesonide nasal spray and levocetirizine, alone and in combination.

Detailed description

randomized, open-label, three arm, parallel group, multi-center study

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Ciclesonide	200 ㎍ once daily
DRUG	Levocetirizine	5mg once daily
DRUG	Ciclesonide & Levocetirizine	* Omnaris (ciclesonide) 200 ㎍ once daily * Levocetirizine 5mg once daily

Timeline

• Start date: 2011-01-01
• Primary completion: 2012-07-01
• Completion: 2012-07-01
• First posted: 2011-09-08
• Last updated: 2012-09-06

Locations

1 site across 1 country: South Korea